{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:58:46Z","timestamp":1772639926801,"version":"3.50.1"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    C\n                    <jats:italic>andida parapsilosis<\/jats:italic>\n                    has emerged as an important nosocomial pathogen. In the present study, a checkerboard broth microdilution method was performed to investigate the in vitro activities of caspofungin (CAS) in combination with amphotericin B (AMB) against three clinical isolates of\n                    <jats:italic>C. parapsilosis<\/jats:italic>\n                    . Although there was a significant reduction of the MIC of one or both drugs used in combination, an indifferent interaction (fractional inhibitory concentration index greater than 0.50 and less than or equal to 4.0) was observed in 100% of cases. This finding was confirmed by killing curve studies. By a disk diffusion assay, the halo diameters produced by antifungal agents in combination were often significantly greater than those produced by each drug alone. Antagonism was never observed. In a murine model of systemic candidiasis, CAS at either 0.25 or 1 mg\/kg\/day combined with AMB at 1 mg\/kg\/day was significantly more effective than each single drug at reducing the colony counts in kidneys. Higher doses of the echinocandin (i.e., 5 and 10 mg\/kg\/day) combined with the polyene did not show any advantage over CAS alone. Overall, our study showed a positive interaction of CAS and AMB against\n                    <jats:italic>C. parapsilosis<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1128\/aac.00880-06","type":"journal-article","created":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T05:40:49Z","timestamp":1165902049000},"page":"941-945","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Caspofungin in Combination with Amphotericin B against\n                    <i>Candida parapsilosis<\/i>"],"prefix":"10.1128","volume":"51","author":[{"given":"Francesco","family":"Barchiesi","sequence":"first","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Spreghini","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Tomassetti","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Giannini","sequence":"additional","affiliation":[{"name":"Centro di Gestione Presidenza Medicina e Chirurgia, Universita\u0300 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Scalise","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2333"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2546-2549.2005"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.9.3317-3322.2004"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2326"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1293-1297.2006"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14472-8"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/375080"},{"key":"e_1_3_1_9_2","first-page":"121","volume":"20","year":"2003","unstructured":"Espinel-Ingroff, A. 2003. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev. Iberoam. Micol.20:121-136.","journal-title":"Rev. Iberoam. Micol."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.9.1937"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg230"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.693-715.2004"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.5.1782-1787.2006"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021585"},{"key":"e_1_3_1_15_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeast 2nd ed. Approved standard M27-A2. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.8.3475-3482.2004"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4895-4902.2005"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/376906"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.3.852-856.2002"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1068-1071.2003"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/499057"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.2128"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/323401"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000128781.77600.6f"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00880-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00880-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T14:19:29Z","timestamp":1645453169000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00880-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1128\/AAC.00880-06"],"URL":"https:\/\/doi.org\/10.1128\/aac.00880-06","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1057711.509621","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"2006-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-11-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}